Thrombomodulin domains attenuate atherosclerosis by inhibiting thrombin-induced endothelial cell activation

Cardiovascular Research

Volumn 92, Issue 2, 2011, Pages 317-327

  Wei, Hsi Ju ^a   Li, Yi Heng ^a,b   Shi, Guey Yueh ^a,b   Liu, Shu Lin ^b   Chang, Po Chiao ^a,b   Kuo, Cheng Hsiang ^a,b   Wu, Hua Lin ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Protease activated receptor 1; Thrombin; Thrombomodulin

Indexed keywords

ALANINE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTIC ACID; CALCIUM ION; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 1; RECOMBINANT THROMBOMODULIN; THROMBIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CAROTID ARTERY; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; THROMBIN TIME; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BINDING SITES; BLOOD COAGULATION; CALCIUM; CAROTID ARTERY DISEASES; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PEPTIDE FRAGMENTS; PERMEABILITY; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTOR, PAR-1; RECOMBINANT PROTEINS; THROMBIN; THROMBOMODULIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 80054108282     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr220     Document Type: Article

References (35)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Borissoff JI, Spronk HMH, Heeneman S, ten Cate H. Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res 2009;82:392-403.
3. Colotta F, Sciacca FL, Sironi M, LuiniW, Rabiet MJ, Mantovani A. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin. Am J Pathol 1994;144:975-985. (Pubitemid 24160638)
4. Kaplanski G, Marin V, Fabrigoule M, Boulay V, Benoliel A-M, Bongrand P et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood 1998;92:1259-1267. (Pubitemid 28369039)
5. Martorell L, Martínez-González J, Rodríguez C, Gentile M, Calvayrac O, Badimon L. Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 2008;99:305-315. (Pubitemid 351230960)
6. Cheung W-m, DíAndrea MR, Andrade-Gordon P, Damiano BP. Altered vascular injury responses in mice deficient in protease-activated receptor-1. Arterioscler Thromb Vasc Biol 1999;19:3014-3024. (Pubitemid 30029832)
7. Nelken NA, Soifer SJ, O'Keefe J, Vu TK, Charo IF, Coughlin SR. Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 1992;90: 1614-1621.
8. Stearns DJ, Kurosawa S, Esmon CT. Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation. J Biol Chem 1989;264:3352-3356. (Pubitemid 19063390)
9. Li Y-H, Liu S-L, Shi G-Y, Tseng G-H, Liu P-Y, Wu H-L. Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model. Thromb Haemost 2006;95:128-133.
10. Shi C-S, Shi G-Y, Hsiao S-M, Kao Y-C, Kuo K-L, Ma C-Y et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood 2008;112:3661-3670.
11. Nagashima M, Lundh E, Leonard JC, Morser J, Parkinson JF. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. J Biol Chem 1993;268:2888-2892. (Pubitemid 23057924)
12. World Medical Association Declaration of Helsinki. Cardiovasc Res 1997;35:2-4.
13. Enomoto N, Yamashina S, Schemmer P, Rivera CA, Bradford BU, Enomoto A et al. Estriol sensitizes rat Kupffer cells via gut-derived endotoxin. Am J Physiol Gastrointest Liver Physiol 1999;277:G671-677. (Pubitemid 29458241)
14. Liu S-L, Li Y-H, Shi G-Y, Tang S-H, Jiang S-J, Huang C-W et al. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice. Cardiovasc Res 2009;82:161-169.
15. Lutgens E, Gorelik L, Daemen MJAP, de Muinck ED, Grewal IS, Koteliansky VE et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999;5: 1313-1316. (Pubitemid 29535611)
16. Sukhova GK, Wang B, Libby P, Pan J-H, Zhang Y, Grubb A et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005;96:368-375. (Pubitemid 40279912)
17. Hein L, Ishii K, Coughlin SR, Kobilka BK. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J Biol Chem 1994;269:27719-27726.
18. Malik AB, Fenton JW 2nd. Thrombin-mediated increase in vascular endothelial permeability. Semin Thromb Hemost 1992;18:193-199.
19. Chiang H-Y, Korshunov VA, Serour A, Shi F, Sottile J. Fibronectin is an important regulator of flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol 2009;29:1074-1079.
20. Kojima Y, Kundu RK, Cox CM, Leeper NJ, Anderson JA, Chun HJ et al. Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse. Cardiovasc Res 2010;87:156-165.
21. Lum H, Aschner JL, Phillips PG, Fletcher PW, Malik AB. Time course of thrombin-induced increase in endothelial permeability: relationship to Ca2+i and inositol polyphosphates. Am J Physiol Lung Cell Mol Physiol 1992;263:L219-L225.
22. Parkinson J, Bang N, Garcia J. Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombin. Arterioscler Thromb Vasc Biol 1993;13:1119-1123. (Pubitemid 23195815)
23. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997;17:2238-2244. (Pubitemid 28057127)
24. Stoop AA, Lupu F, Pannekoek H. Colocalization of thrombin, PAI-1, and vitronectin in the atherosclerotic vessel wall: a potential regulatory mechanism of thrombin activity by PAI-1/vitronectin complexes. Arterioscler Thromb Vasc Biol 2000;20:1143-1149. (Pubitemid 30207594)
25. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol 1994;14:133-140.
26. Fuentes-Prior P, Iwanaga Y, Huber R, Pagila R, Rumennik G, Seto M et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 2000;404:518-525. (Pubitemid 30186897)
27. Oganesyan V, Oganesyan N, Terzyan S, Qu D, Dauter Z, Esmon NL et al. The crystal structure of the endothelial protein C receptor and a bound phospholipid. J Biol Chem 2002;277:24851-24854. (Pubitemid 34951783)
28. Shu F, Kobayashi H, Fukudome K, Tsuneyoshi N, Kimoto M, Terao T. Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Lett 2000;477:208-212. (Pubitemid 30450168)
29. Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A et al. Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide. Circulation 2001;104:1171-1175. (Pubitemid 32830403)
30. Esmon CT. Protein C pathway in sepsis. Ann Med 2002;34:598-605. (Pubitemid 36113819)
31. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001;276:11199-11203. (Pubitemid 38089304)
32. Inoue K, Kawahara K-i, Biswas KK, Ando K, Mitsudo K, Nobuyoshi M et al. HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol 2007;16:136-143. (Pubitemid 46729668)
33. Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004;24:2320-2325. (Pubitemid 39658036)
34. Crikis S, Zhang XM, Dezfouli S, Dwyer KM, Murray-Segal LM, Salvaris E et al. Antiinflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice. Am J Transplant 2010;10:242-250.
35. Ito T, Kawahara K-i, Okamoto K, Yamada S, Yasuda M, Imaizumi H et al. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler Thromb Vasc Biol 2008;28:1825-1830.